Login / Signup

An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France.

Patrick BlinPascal DemolyMartine DrouetBruno FalissardSéverine Lignot-MaleyranHélène MaiziSimon LorrainRégis LassalleCécile Droz-PerroteauNicholas MooreMathieu Molimard
Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2018)
5GPE-SLIT use was generally consistent with prescribing recommendations and was associated with an improvement of AR severity, with resolution of the principal AR symptoms in around half the patients treated.Trial registration EUPAS9358. Registered 13 May 2015. Not prospectively registered. http://www.encepp.eu/encepp/viewResource.htm?id=16229.
Keyphrases
  • primary care
  • study protocol
  • phase iii
  • clinical trial
  • oxidative stress
  • phase ii
  • clinical practice
  • single molecule
  • allergic rhinitis
  • anti inflammatory
  • randomized controlled trial
  • adverse drug
  • open label
  • double blind